中國生物製藥(01177.HK)公布，限制性股份獎勵計劃受託人今日(15日)從市場進一步購買500萬股股份，每股平均價2.68元，涉額1,340.25萬元。
中生製藥(01177.HK)受託人購買500萬股 涉1,340.3萬元
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.